Low-density lipoprotein receptor-related protein-1 (LRP1) is expressed on the BBB and overexpressed in glioblastoma, which makes it the most used receptor for penetrating the BBB in drug development for the treatment of brain diseases and becomes an ideal treatment for brain cancer [101–103]. This evidence concerns the gene LRP1 and brain cancer.